Arformoterol Tartrate Inhalation Solution
Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL These highlights do not include all the information needed to use ARFORMOTEROL TARTRATE INHALATION SOLUTION safely and effectively. See full prescribing information for ARFORMOTEROL TARTRATE INHALATION SOLUTION ARFORMOTEROL TARTRATE INHALATION SOLUTION Initial U.S. Approval: 2006
Approved
Approval ID
ef524b4c-68d7-c464-e053-2a95a90a7f96
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 20, 2023
Manufacturers
FDA
Ritedose Pharmaceuticals, LLC
DUNS: 968062294
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Arformoterol Tartrate Inhalation Solution
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code76204-026
Application NumberANDA214736
Product Classification
M
Marketing Category
C73584
G
Generic Name
Arformoterol Tartrate Inhalation Solution
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateDecember 20, 2023
FDA Product Classification
INGREDIENTS (1)
ARFORMOTEROL TARTRATEActive
Quantity: 15 ug in 2 mL
Code: 5P8VJ2I235
Classification: ACTIM